Synaptic mitochondrial dysfunction and septin accumulation are linked to complement-mediated synapse loss in an Alzheimer's disease animal model

BA Györffy, V Tóth, G Török, P Gulyássy… - Cellular and Molecular …, 2020 - Springer
Synaptic functional disturbances with concomitant synapse loss represent central
pathological hallmarks of Alzheimer's disease. Excessive accumulation of cytotoxic amyloid …

Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer's disease mouse models

B Dejanovic, T Wu, MC Tsai, D Graykowski… - Nature Aging, 2022 - nature.com
Microglia and complement can mediate neurodegeneration in Alzheimer's disease (AD). By
integrative multi-omics analysis, here we show that astrocytic and microglial proteins are …

Complement-mediated synapse loss in Alzheimer's disease: mechanisms and involvement of risk factors

L Wen, D Bi, Y Shen - Trends in Neurosciences, 2024 - cell.com
The complement system is increasingly recognized as a key player in the synapse loss and
cognitive impairments observed in Alzheimer's disease (AD). In particular, the process of …

Synaptic dysfunction and septin protein family members in neurodegenerative diseases

M Marttinen, KMA Kurkinen, H Soininen… - Molecular …, 2015 - Springer
Cognitive decline and disease progression in different neurodegenerative diseases typically
involves synaptic dysfunction preceding the neuronal loss. The synaptic dysfunction is …

Terminal complement pathway activation drives synaptic loss in Alzheimer's disease models

SM Carpanini, M Torvell, RJ Bevan, RAJ Byrne… - Acta Neuropathologica …, 2022 - Springer
Complement is involved in developmental synaptic pruning and pathological synapse loss
in Alzheimer's disease. It is posited that C1 binding initiates complement activation on …

Proteomic and functional alterations in brain mitochondria from Tg2576 mice occur before amyloid plaque deposition

F Gillardon, W Rist, L Kussmaul, J Vogel, M Berg… - …, 2007 - Wiley Online Library
Synaptic dysfunction is an early event in Alzheimer's disease patients and has also been
detected in transgenic mouse models. In the present study, we analyzed proteomic changes …

[HTML][HTML] Insight into the role of phosphatidylserine in complement-mediated synapse loss in Alzheimer's disease

D Sokolova, T Childs, S Hong - Faculty Reviews, 2021 - ncbi.nlm.nih.gov
The innate immune system plays an integral role in the brain. Synaptic pruning, a
fundamental process in developmental circuit refinement, is partially mediated by …

The synaptic proteome in Alzheimer's disease

RYK Chang, AS Nouwens, PR Dodd… - Alzheimer's & Dementia, 2013 - Elsevier
Background Synaptic dysfunction occurs early in Alzheimer's disease (AD) and is
recognized to be a primary pathological target for treatment. Synapse degeneration or …

Alzheimer's disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression

S Meftah, J Gan - Frontiers in Synaptic Neuroscience, 2023 - frontiersin.org
The synapse has consistently been considered a vulnerable and critical target within
Alzheimer's disease, and synapse loss is, to date, one of the main biological correlates of …

Synaptic pathology: a shared mechanism in neurological disease

CM Henstridge, E Pickett, TL Spires-Jones - Ageing research reviews, 2016 - Elsevier
Synaptic proteomes have evolved a rich and complex diversity to allow the exquisite control
of neuronal communication and information transfer. It is therefore not surprising that many …